ETC-159 In Combination With Pembrolizumab In Advanced MSS/pMMR Ovarian Cancers
Clinical trial NCT06513624 · RECRUITING
Trial details
- NCT number
- NCT06513624
- Sponsor
- National University Hospital, Singapore
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-09
- Primary completion
- 2026-12-31
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.